¶ Selecta Biosciences
.png)
Selecta Biosciences, Inc. is an American biotechnology company based in Watertown, Massachusetts. It trades on the NASDAQ under the ticker name SELB.[1]
¶ History
Selecta Biosciences was founded in 2008 by Omid Farokhzad, after its incorporation in 2007.[2][3] The company was founded to develop immunomodulatory nanoparticles for the treatment and prevention of human diseases. Early investors in the then-private startup included Polaris Partners and Flagship Pioneering, the latter of which would soon also launch Moderna.[4][5] They were joined in February 2009 by additional investments from NanoDimension and professor Timothy Springer (a founding investor in Moderna).[6]
In December 2021, Selecta invested in a Series B funding round for Cyrus Biotechnology.[7]
¶ Activities
The company has had license and collaboration agreements with:[3:1][8]
- Asklepios BioPharmaceutical (AskBio)
- Ginkgo Bioworks
- IGAN Biosciences
- Massachusetts Institute of Technology (MIT)
- Sarepta Therapeutics
- Shenyang Sunshine Pharmaceutical Co.
- Spark Therapeutics
- Swedish Orphan Biovitrum (Sobi)
- Takeda Pharmaceuticals
¶ Patents
| Number | Title | Date filed | Inventor(s) |
|---|---|---|---|
| WO2012149411 | Controlled release of immunosuppressants from synthetic nanocarriers | April 27, 2012 | David Altreuter, Aaron Griset, Roberto Maldonaldo |
¶ Organization
| Name | Position | Notes |
|---|---|---|
| Carsten Brunn | President and CEO[9] | Bayer, European Federation of Pharmaceutical Industries and Associations Japan, Eli Lilly, Novartis, Basilea Pharmaceuticals, Bausch & Lomb, Surface Oncology |
| Lloyd Johnston | Chief Operations Officer | Alkermes, Advanced Inhalation Research (AIR), University of New South Wales |
| Takeshi Kei Kishimoto | Chief Science Officer | Momenta Pharmaceuticals, Millennium Pharmaceuticals, Boehringer Ingelheim |
| Kristen Baldwin | Chief People Officer | LIVEKINDLY Collective, CEO.works, Bayer, Otsuka Pharmaceuticals |
| Peter Traber | Chief Medical Officer | Alacrita Consulting, Morphic Therapeutic, Galectin Therapeutics, GlaxoSmithKline, Baylor College of Medicine, University of Pennsylvania Health System, University of Pennsylvania, Caladrius Biosciences |
| Blaine Davis | Chief Financial Officer | Protera Therapeutics, Insmed, Endo International, Endo Ventures, Bristol-Myers Squibb |
| Matthew Bartholomae | General Counsel, Secretary | Minerva Neurosciences |
| Ann Donohue | Vice President of Finance & Controller | - |
| Ulrich von Andrian | Co-Founder and Co-Chair of the Scientific Advisory Board | - |
| Carrie Cox | Chairman | Humacyte, Schering-Plough, Pharmacia & Upjohn, Texas Instruments, Cardinal Health, Organon, Celgene, Array BioPharma, electroCore, Prism Pharmaceutical |
| Timothy Barabe | Director | ArQule, Veeva Systems, Vigilant Biosciences, Affymetrix, Human Genome Sciences, Regent Medical, Sandoz |
| Nishan de Silva | Director | AFYX Therapeutics, Poseida Therapeutics, Ligand Pharmaceuticals, Warburg Pincus, McKinsey & Company |
| Scott Myers | Director | AMAG Pharmaceuticals, Rainier Therapeutics, Cascadian Therapeutics, Aerocrine, UCB, Johnson & Johnson, Trillium Therapeutics, Harpoon Therapeutics, Dynavax Technologies |
| Aymeric Sallin | Director | NanoDimension, H55, Crocus Technology, Tarveda Therapeutics, Swiss Academy of Engineering Science, École Polytechnique Fédérale de Lausanne (EPFL) |
| Timothy Springer | Director | Harvard Medical School, Boston Children's Hospital, LeukoSite, National Academy of Sciences |
| Patrick Zenner | Director | Roche, ArQule, West Pharmaceutical Services |
| Shuang Sarah Wu | Senior Manager of Strategy and Business Development (former)[10][11] | Now at Pfizer |
¶ Investors
Companies that have invested in/provided funding for Selecta include:[12][13][7:1]
- Artal Group
- BlackRock
- Boxer Capital
- EcoR1 Capital
- Eminent Venture Capital
- Endurant Capital Management
- Flagship Pioneering
- I2BF Global Ventures
- JPMorgan Chase
- Leukon Investments
- Mangrove Partners
- Millennium Management
- NanoDimension
- Osage University Partners (OUP)
- Oxford Finance
- Polaris Partners
- Sanofi Ventures
- Silicon Valley Bank (SVB)
- Sphera Funds Management
- Vanguard
¶ External links
Selecta Biosciences Inc (SELB) Stock Price & News. Google Finance. Retrieved February 3, 2023, from https://www.google.com/finance/quote/SELB:NASDAQ ↩︎
Selecta Biosciences - Crunchbase Company Profile & Funding. Crunchbase. Retrieved February 3, 2023, from https://www.crunchbase.com/organization/selecta-biosciences ↩︎
Selecta Biosciences, Inc. (SELB) Company Profile & Facts. Yahoo Finance. Retrieved October 16, 2021, from https://web.archive.org/web/20211016161609/https://finance.yahoo.com/quote/SELB/profile?p=SELB ↩︎ ↩︎
Bratzler, R. (2009, February 25). Selecta Biosciences, Inc. Closes $15.1M Series B Financing. Flagship Pioneering. http://archive.today/2023.02.03-174945/https://www.flagshippioneering.com/press/selecta-biosciences-inc-closes-151m-series-b-financing ↩︎
Moderna. Flagship Pioneering. Retrieved September 15, 2022, from http://archive.today/2022.09.15-150329/https://www.flagshippioneering.com/companies/moderna ↩︎
Tognini, G. (2020, May 16). Exclusive: Meet The Harvard Professor Who Became A Billionaire Thanks To Coronavirus. Forbes. https://web.archive.org/web/20230203175707/https://www.forbes.com/sites/giacomotognini/2020/05/16/exclusive-harvard-professor-who-became-a-billionaire-thanks-to-moderna-talks-about-his-investing/?sh=5ac096b6b8d7 ↩︎
Selecta Biosciences - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved February 3, 2023, from https://www.crunchbase.com/organization/selecta-biosciences/company_financials ↩︎ ↩︎
Partnerships. Selecta Biosciences. Retrieved October 13, 2022, from https://web.archive.org/web/20221013150325/https://selectabio.com/partnerships/ ↩︎
About Us. Selecta Biosciences. Retrieved February 4, 2023, from http://archive.today/2023.02.04-045241/https://selectabio.com/about-us/ ↩︎
SHUANG (SARAH) WU, Gerente Senior, Estrategia y Desarrollo de Negocios, Selecta Biosciences. GetEmail.io. Retrieved February 3, 2023, from https://web.archive.org/web/20230203004058/https://b2b.getemail.io/shuang-sarah-wu-pfizer-person-company-21927493-3411511.html ↩︎
NOSTUPID3. (2023, January 31). 微博. Weibo. http://archive.today/2023.02.03-003826/https://m.weibo.cn/status/MqRi6vN9l?jumpfrom=weibocom%23&gid=1&pid=8 ↩︎
Selecta Biosciences, Inc. (SELB) Stock Major Holders. Yahoo Finance. Retrieved February 3, 2023, from https://finance.yahoo.com/quote/SELB/holders?p=SELB ↩︎
Companies. Flagship Pioneering. Retrieved January 15, 2023, from https://web.archive.org/web/20230115044601/https://www.flagshippioneering.com/companies ↩︎